DV
Dividend Vision

APVO — Aptevo Therapeutics Inc

Aptevo Therapeutics Inc (APVO)

Its deepest 1-year drawdown was 90.9%.

# Summary Based on the data provided, this appears to be a single equity security rather than an ETF. Aptevo Therapeutics Inc is a biopharmaceutical company stock that does not currently offer dividend distributions. The security lacks standard dividend metrics such as yield, distribution frequency, and expense ratio data, making it unsuitable for income-focused dividend investors seeking regular cash returns.

APVO key facts

Asset type
Stock
Asset class
Equity
Inception date
07/20/2016
Last close
$2.94
Market cap
$5,906,537
Average volume
79300.0
Payment date
03/27/2020
Beta
1.671
Payout ratio
0.0
P/E ratio
0.0032
Forward P/E
3.8895
EPS
$1,488.13